WorkflowHistopathologyProcedure concept

Frozen section in skin oncology

Intraoperative frozen section ยท cryostat section ยท IOC

Frozen section permits rapid intra-operative histological assessment of surgical margins through cryostat-cut tissue (10-20 minutes per specimen). In skin oncology its main applications are intra-operative margin assessment at non-Mohs centres, in difficult anatomical locations, in periocular surgery and during salvage / complex reconstruction. Frozen section is not equivalent to formal Mohs micrographic surgery โ€” there are important false-negative and false-positive caveats that affect its place in the cSCC, BCC, melanoma in situ and lentigo maligna pathways.

CurrentLast reviewed 16 May 2026

Technique

  • Specimen frozen rapidly to ~โˆ’20 ยฐC in a cryostat; 4-8 ฮผm sections cut, stained with H&E (or rapid IHC where available).
  • Turnaround typically 10-20 minutes per specimen from receipt.
  • Operator must communicate clearly with pathologist โ€” orientation marker (suture / ink), defect map, clinical question, prior treatments.

Indications in skin oncology

  • Intra-operative margin clearance at non-Mohs centres for high-risk BCC and cSCC at sensitive anatomical sites (periocular, nose, ear, lip).
  • Complex / staged reconstruction โ€” confirm margin clearance before flap inset or graft.
  • Salvage surgery for previously irradiated or recurrent disease.
  • DFSP wide local excision โ€” slow Mohs / en-face permanent sections preferred but frozen section used at centres without Mohs.
  • Microcystic adnexal carcinoma, EMPD โ€” slow Mohs / permanent en-face is preferred (frozen-section accuracy limited).

Limitations and pitfalls

  • Melanocytic lesions: frozen section is unreliable for melanoma in situ / lentigo maligna; freezing artefact, fragmentation and lack of IHC reduce sensitivity. Permanent en-face sections (Mohs-by-permanent-paraffin) or staged excision with rush paraffin is preferred โ€” supported by BAD and ACMS guidance.
  • Sclerosing / morphoeic BCC and infiltrative cSCC: thin strands may be missed in vertical frozen sections.
  • Perineural invasion: hard to identify reliably on frozen section.
  • Freezing artefact, ice crystals and section curling can mimic or hide tumour.
  • Tumour budding and grade assessment less reliable than permanent.

Comparison with Mohs micrographic surgery

  • Mohs: complete circumferential and deep-margin assessment of 100% of the resection margin, en-face frozen sections, integrated surgical / pathological role. Highest cure rates for BCC and cSCC at high-risk sites.
  • Conventional frozen section: typically vertical sections from a partial set of margins; less of the true margin is examined; risk of sampling error.
  • If Mohs unavailable, slow-Mohs / 3D-histology with permanent paraffin sections delivers near-Mohs results without freezing artefact.

Practical considerations

  • Plan operating time and reconstruction strategy assuming frozen-section may upstage and require re-excision.
  • Send selected margins as fresh, orientated specimens with clearly drawn defect map.
  • If margin equivocal: ink and proceed with conservative reconstruction (e.g. delayed graft) pending permanent paraffin.
  • Record all frozen-section reports in the MDT minutes; cross-check against final paraffin report.
  • Audit your frozen-section / paraffin concordance and false-negative / false-positive rates annually as part of clinical governance.

References

  1. Newman J et al. Frozen section margin analysis for cutaneous squamous cell carcinoma: a meta-analysis. Dermatol Surg. 2021;47:744-748.
  2. Rapini RP. Comparison of methods for checking surgical margins. J Am Acad Dermatol. 1990;23:288-294.
  3. British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2021;185:899-920.
  4. Etzkorn JR et al. Frozen section vs permanent section for treatment of melanoma in situ. JAMA Dermatol. 2018;154:1213-1218.
  5. Madan V et al. Non-melanoma skin cancer. Lancet. 2010;375:673-685.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.